Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron therapy and infection incidence in adults with chronic kidney disease
PACTR202511791015107Not yet recruiting
- Sponsor
- Alaa mohamed
- Start
- Dec 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in iron deficiency anemia (IDA) and chronic kidney disease (CKD), sponsored by Alaa mohamed. Primary endpoint: Incidence of infection. Planned start Dec 2025; status: not yet recruiting.
02
Conditions
iron deficiency anemia (IDA)chronic kidney disease (CKD)
Beyond the preview
Go deeper on PACTR202511791015107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511791015107.